Expertise in
100
conditions

Dr. Andrew W. Pippas

Oncology
Regional Oncology LLC
1831 5th Ave, 
Columbus, GA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
100
conditions
Regional Oncology LLC
1831 5th Ave, 
Columbus, GA 

Overview

Andrew Pippas is an Oncologist practicing medicine in Columbus, Georgia.

Dr. Pippas is highly rated in 100 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Pancreatic Cancer, Bone Marrow Aspiration, and Endoscopy.

He is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 44 clinical trials. Dr. Pippas is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in GA

Hospital Affiliations

St Francis Hospital- Emory Healthcare
Piedmont Newnan Hospital, Inc
Piedmont Columbus Regional Midtown
Piedmont Fayette Hospital
Piedmont Columbus Regional Northside

Languages Spoken

English
Hindi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Regional Oncology LLC
1831 5th Ave, Columbus, GA 31904
Other Locations
The Medical Center, Inc Oncology
710 Center St, Columbus, GA 31901
Columbus Ambulatory Healthcare Services Inc.
1800 10th Ave, Columbus, GA 31901

Additional Areas of Focus

Dr. Pippas has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

44 Clinical Trials

Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Enrollment Status: Recruiting
Publish Date: October 28, 2026
Intervention Type: Other, Drug
Study Drug: Carvedilol
Study Phase: Phase 3
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: October 27, 2026
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 26, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Exemestane, Letrozole, Systemic Chemotherapy
Study Phase: Phase 3
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: October 26, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Enrollment Status: Active_not_recruiting
Publish Date: October 26, 2026
Intervention Type: Procedure, Drug, Other
Study Drug: Pazopanib Hydrochloride
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: October 26, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Enrollment Status: Active_not_recruiting
Publish Date: October 23, 2026
Intervention Type: Drug
Study Phase: Phase 3
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 23, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
EROS: Engendering Reproductive Health Within Oncologic Survivorship
EROS: Engendering Reproductive Health Within Oncologic Survivorship
Enrollment Status: Active_not_recruiting
Publish Date: October 06, 2026
Intervention Type: Other
Study Phase: Not Applicable
Prospective Validation Trial of Taxane Therapy (Docetaxel or Weekly Paclitaxel) and Risk of Chemotherapy-Induced Peripheral Neuropathy in African American Women
Prospective Validation Trial of Taxane Therapy (Docetaxel or Weekly Paclitaxel) and Risk of Chemotherapy-Induced Peripheral Neuropathy in African American Women
Enrollment Status: Active_not_recruiting
Publish Date: October 06, 2026
Intervention Type: Other, Drug
Study Drugs: Docetaxel, Paclitaxel
Study Phase: Phase 2
View 9 Less Clinical Trials

10 Total Publications

Engendering Reproductive Health Within Oncologic Survivorship Trial, ECOG-ACRIN E1Q11.
Engendering Reproductive Health Within Oncologic Survivorship Trial, ECOG-ACRIN E1Q11.
Journal: JCO oncology practice
Published: April 28, 2026
Similar Doctors
Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required

Columbus Ambulatory Healthcare Services Inc.

1800 10th Ave, 
Columbus, GA 
 (0.5 miles away)
706-571-1120
Languages Spoken:
English, Amharic, Arabic, Bengali
See accepted insurances
Accepting New Patients
Offers Telehealth

Gregory Sfakianos is an Oncologist practicing medicine in Columbus, Georgia. Dr. Sfakianos is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Ovarian Cancer, Endometrial Cancer, and Ovarian Carcinosarcoma. Dr. Sfakianos is currently accepting new patients.

Expertise in
66
conditions
Expertise in
66
conditions
Referral may be required

Piedmont Columbus Regional Midtown

710 Center St, 
Columbus, GA 
 (0.2 miles away)
706-320-8780
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Peter Jiang is an Oncologist practicing medicine in Columbus, Georgia. Dr. Jiang is highly rated in 66 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Thrombocytopenia, Chronic Familial Neutropenia, Bone Marrow Aspiration, and Endoscopy. Dr. Jiang is currently accepting new patients.

Expertise in
72
conditions
Dr. Suresh O. Nukala
Hematology | Oncology
Expertise in
72
conditions
Dr. Suresh O. Nukala
Hematology | Oncology
Referral may be required

Piedmont Columbus Regional Midtown

710 Center St, 
Columbus, GA 
 (0.2 miles away)
706-320-8780
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Suresh Nukala is a Hematologist and an Oncologist practicing medicine in Columbus, Georgia. Dr. Nukala is highly rated in 72 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, Bone Marrow Aspiration, and Gastrostomy. Dr. Nukala is currently accepting new patients.

Expertise in
39
conditions
Dr. Mohammad J. Ranginwala
Hematology | Oncology
Expertise in
39
conditions
Dr. Mohammad J. Ranginwala
Hematology | Oncology
Referral may be required

Regional Oncology LLC

1831 5th Ave, 
Columbus, GA 
 (0.1 miles away)
706-320-8780
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mohammad Ranginwala is a Hematologist and an Oncologist practicing medicine in Columbus, Georgia. Dr. Ranginwala is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Familial Colorectal Cancer, Lynch Syndrome, and Bone Marrow Aspiration. Dr. Ranginwala is currently accepting new patients.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

Regional Oncology LLC

1831 5th Ave, 
Columbus, GA 
 (0.1 miles away)
706-320-8780
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Wilbur Bassett is an Oncologist practicing medicine in Columbus, Georgia. Dr. Bassett is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Hemangioma Thrombocytopenia Syndrome, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Chronic B-Cell Leukemia (CBCL). Dr. Bassett is currently accepting new patients.

Expertise in
11
conditions
Dr. Srividya Srinivasamaharaj
Hematology | Oncology
Expertise in
11
conditions
Dr. Srividya Srinivasamaharaj
Hematology | Oncology
Referral may be required

Regional Oncology LLC

1831 5th Ave, 
Columbus, GA 
 (0.1 miles away)
706-320-8700
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Srividya Srinivasamaharaj is a Hematologist and an Oncologist practicing medicine in Columbus, Georgia. Dr. Srinivasamaharaj is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Pleuropulmonary Blastoma, Pancreatic Cancer, Colonoscopy, and Endoscopy. Dr. Srinivasamaharaj is currently accepting new patients.

Frequently Asked Questions about Dr. Andrew W. Pippas

How do I make an appointment with Dr. Andrew W. Pippas?

You can book an appointment with Dr. Andrew W. Pippas by calling their office at 706-321-6600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andrew W. Pippas a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew W. Pippas is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andrew W. Pippas specialize in?

While Dr. Andrew W. Pippas is a Oncology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Andrew W. Pippas participate in research or clinical trials?

Yes. Dr. Andrew W. Pippas has published 10 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Andrew W. Pippas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Andrew W. Pippas accept my insurance?

Dr. Andrew W. Pippas accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 706-321-6600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pippas's expertise for a condition
ConditionClose
    View All 17 Distinguished Conditions
    View All 83 Advanced Conditions
    View All 91 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile